We have located links that may give you full text access.
EcircPred: Sequence and secondary structural property based computational identification of exonic circular RNAs.
Computational Biology and Chemistry 2018 August 20
Circular RNAs are new class of stable non-coding RNAs, whose expressions are specific to tissues as well as developmental stages and reported to act as gene regulators. Conspicuous presences of some of them as biomarkers for cancers, aging etc. are well reported. Biogenesis of circular RNA competes with Pre-mRNA splicing using the same splicing machinery and gene loci. Also, some circular RNAs are reported to have open reading frames and internal ribosome entry site for ribosome binding, which increases the chance of overlapping features among circular and mRNA transcripts. Therefore, discriminating the Exonic circular RNAs and mRNAs solely through sequence properties is challenging. However, possible discriminating factors, such as, reports on non-canonical arrangement of exons in circular RNAs were cited. This study was dedicated to classify Circular RNAs from mRNAs by recruiting features extracted from sequences as well as predicted secondary structures and ANN classifier models for all these feature types. The features were statistics of di-nucleotide index, emission probability of RNA sequences and entropy of di-nucleotides. Finally a simple decision voting was applied to combine decisions obtained from multiple classifiers. After performing 10 fold cross validation we obtained average values of efficiency, sensitivity, specificity and Mathews correlation coefficient as 0.8374, 0.8544, 0.8203 and 0.6753 respectively. In the backdrop of few reports of identification of circular RNAs from constitutive exons and other long non-coding RNAs, this is the first report of discriminating exonic circular RNAs from mRNAs using sequence and sequence-derived properties.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app